Language barriers and human subjects research.

Over at On Becoming a Domestic and Laboratory Goddess, Dr. Isis looks at challenges of opening up participation in human subjects research to potential subjects who are not fluent English speakers:

When one enters the university hospital here at MRU, there are a number of skilled and qualified translators that are available to help patients that can’t dialogue in English to communicate with health care staff. They are able to sufficiently translate documents to allow a patient to provide some reasonable level of consent (my M.D. blog buddies can debate the quality of said consent). There is no infrastructure like this in research at most major research universities. Consent forms are written in English. Even if I could provide verbal translation for this man, it would not be ethical for him to sign a document in a language he cannot read himself and understand. Thus, it all more or less becomes a moot point. Beyond that, while I am a fluent Spanish speaker, I am not a qualified medical interpreter. I have no idea how to say “indwelling arterial catheter.” Babelfish says it’s, “catéter arterial dejado en un órgano.” I know that can’t be right, but who am I to question Babelfish?. Even if I were completely confident saying, “We are studying the physiological effect of [Dr. Isis’s favorite stimulus] on vascular function” in Spanish, it’s not the best use of my time as a researcher (unless one of you folks want to write me in for 10% effort, and then I will make sure I learn to say it).
So, the question is, is there an ethical issue here at all … ? The National Institutes of Health mandate the inclusion of minorities in human research studies. In our area, members of the major minority groups often do not speak fluent English. However, the translation of study documents and the hiring of an interpreter to help with the consent is expensive and I have never known an investigator to include a translator in a budget when they could have a technician. Furthermore, if you are willing to translate a consent form into one language, what about all of the other languages that might be spoken in the area around where the study is being conducted, no matter how rare? Indeed, most people I know make the decision that the ability to understand and communicate in English at a 6th grade level is a criteria for participation.
Yet, if the ability to speak English is a criteria for participation, then we by default fail to include particular groups in research cohorts. We’re back to research cohorts being comprised of middle-aged white men.

(Bold emphasis added.)
It looks to me like there is an ethical issue here. Plus, I think I see a scientific issue. Together, the two kinds of issues make me think that tackling the issue of translation should be a priority for researchers (and for the agencies funding their work).

Continue reading

Book review: Wired for War.

WiredForWar.jpg
Wired for War: The Robotics Revolution and Conflict in the 21st Century
by P.W. Singer
New York: Penguin
2009

For some reason, collectively humans seem to have a hard time seeing around corners to anticipate the shape our future will take. Of those of us who remember email as a newish thing, I suspect most of us had no idea how much of our waking lives would come to be consumed by it. And surely I am not the only one who attended a lab meeting in which a visiting scholar mentioned a speculative project to build something called the World Wide Web and wondered aloud whether anything would come of it.
In the realm of foreign conflicts, our shared expectations also seem to land some distance from reality, as missions that are declared “accomplished” (or all but) stretch on with no clear end in sight.
In Wired for War, Brookings Institution senior fellow P.W. SInger asks us to try to peer around some important corners to anticipate the future of robotics in our conflicts and in our lives more broadly. The consequences of not doing so, he warns, may have significant impacts on policy, law, ethics, and our understanding of ourselves and our relation to our fellow humans.

Continue reading

Office of Research Integrity takes ‘final action’ in Luk Van Parijs case.

You may recall the case of Luk Van Parijs, the promising young associate professor of biology at MIT who was fired in October of 2005 for fabrication and falsification of data. (I wrote about the case here and here.)

Making stuff up in one’s communications with other scientists, whether in manuscripts submitted for publication, grant applications, scientific presentation, or even personal communications, is a very bad thing. It undermines the knowledge-building project in which the community of science is engaged. As an institution serious about its role in this knowledge-building enterprise, MIT did well to identify Van Parijs as a bad actor, to take him out of play, and to correct the scientific record impacted by Van Parijs’s lies.

MIT wasn’t the only institution with a horse in this race, though. Given that many of Van Parijs’s misrepresentations occurred in work supported by federal grants, or in application for federal grant money, the U.S. Office of Research Integrity (ORI), an agency of the Department of Health and Human Services, launched a thorough investigation of the case. As reported in the Federal Register, ORI has now taken final action in the Van Parijs case:

Continue reading

Physics professor gives common sense the day off.

Sadly, the Houston Chronicle brings us another story about an academic caught plagiarizing. The academic in question is Rambis M. Chu, a tenured associate professor of physics at Texas Southern University, who is currently under investigation for plagiarism in a grant proposal he submitted to the U.S. Army Research Laboratory.
Since the investigation is still under way, I’m open to the possibility that Chu will present some evidence to demonstrate his innocence here. However, should the facts reported in the Houston Chronicle stand up to scrutiny, this is shaping up to be one of those cases where the accused took leave of common sense.
From the Houston Chronicle article:

Continue reading

A drug company, a psychiatrist, and an inexplicable failure to disclose conflicts of interest.

Charles B. Nemeroff, M.D., Ph.D., is a psychiatrist at Emory University alleged by congressional investigators to have failed to report a third of the $2.8 million (or more) he received in consulting fees from pharmaceutical companies whose drugs he was studying.
Why would congressional investigators care? For one thing, during the period of time when Nemeroff received these consulting fees, he also received $3.9 million from NIH to study the efficacy of five GlaxoSmithKline drugs in the treatment of depression. When the government ponies up money for scientific research, it has an interest in ensuring that the research will produce reliable knowledge.
GlaxoSmithKline, of course, has an interest in funding studies that show that its drugs work really well.

Continue reading

Gimme the money — hold the oversight.

From time to time on this blog, we discuss the obligation scientists assume by virtue of accepting public money to fund their research. These obligations may include sharing knowledge with the public (since public money helped make that knowledge). And they also include playing by the public’s rules as enshrined in various federal regulations concerning scientific research.
If a scientist takes public money, she expects there will be some public oversight. That’s just how it goes.
Of course, working from this mindset makes it much harder for me to fathom how someone (say a Secretary of the Treasury) could ask for a big chunk of public money (say $700 billion) with no oversight whatsoever. Indeed, in trying to make sense of such a request, I find myself entertaining some pretty odd hypotheses:

Continue reading

Retired congresscritter offers communication tips to scientists.

The congresscritter in question being Sherwood Boehlert, who represented New York’s 24th Congressional district (1983-2007), and chaired the House Science Committee (2001-2007). Boehlert offers this advice in a video called “Speaking for Science: Bringing Your Message to Policymakers,” available for download from the American Chemical Society website.*
The video presents two scenarios in which a group of scientists meets with their Congressional representative (who happens to be a member of the House Science Committee, played by Boehlert). As you might guess, the idea is to contrast the effective meeting with the disastrous one.

Continue reading

Book review: And the Band Played On.

Randy Shilts, And the Band Played On: Politics, People, and the AIDS Epidemic. St. Martin’s Press, 1987.
There are a few books on my shelf that I can read any given number of times without being bored or impatient. One of these is And the Band Played On, a painstaking work of journalism that never feels laborious in the reading — despite being in excess of 600 pages.
Randy Shilts, who was a reporter for the San Francisco Chronicle reporting on AIDS in the early 1980s, assembled an intricate chronological telling of the early unfolding of the AIDS epidemic, from the first glimmerings of awareness of a new disease among doctors, public health workers, and trackers of epidemics, to the reactions of people in communities hit by this new disease (especially the gay communities in New York City and San Francisco), to the responses of politicians and policy makers who, almost without exception, dropped the ball.

Continue reading

Help Kay Weber continue to pursue her case against Fermilab.

You may already have seen this at Absinthe or Zuska’s — if so, consider this post a friendly nudge to move beyond your good intentions toward action.
Kay Weber, who is pursuing a lawsuit against Fermilab for (the details of which sound pretty horrific), has come to a point where the expense of moving the lawsuit forward is personally insurmountable. With a little help from others who support her fight for fair treatment, however, it can be done:

Continue reading

If the science pipeline breaks, the rest of us get hurt, too.

A bunch of other bloggers are discussing the recent statement A Broken Pipeline? Flat Funding of the NIH Puts a Generation of Science at Risk (PDF). I thought I’d say something about the complexities of the situation, and about why non-scientists (whose tax dollars support scientific research funded by the NIH and other government agencies) should care.
The general idea behind funding scientific research with public monies is that such research is expected to produce knowledge that will benefit society. There are problems that non-scientists cannot solve on their own, so we pony up the resources so that scientists can apply their expertise to solving them. As we’ve discussed before, tax-payers seem most interested in the payoff of the research — the knowledge with practical application.
But you can’t get that payoff without scientists.

Continue reading